Evaluation of Efficacy and Safety of BF-200 ALA Used With Photodynamic Therapy in Patients With Actinic Keratosis.

PHASE3CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Actinic Keratosis
Interventions
DRUG

Vehicle

topical treatment for photodynamic therapy combining vehicle application and subsequent illumination with broad or narrow spectrum light sources (after 3 h of drug incubation).

DRUG

BF-200 ALA

topical treatment for photodynamic therapy combining drug application and subsequent illumination with broad or narrow spectrum light sources (after 3 h of drug incubation).

Sponsors
All Listed Sponsors
lead

Biofrontera Bioscience GmbH

INDUSTRY